Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia.
Carella AM, Frassoni F, Pollicardo N, Pungolino E, Ferrero R, Vasallo F, Soracco M, Giordano D, Figari O, Benvenuto F, et al. Carella AM, et al. Among authors: ferrero r. Br J Haematol. 1995 Mar;89(3):535-8. doi: 10.1111/j.1365-2141.1995.tb08360.x. Br J Haematol. 1995. PMID: 7537528 Clinical Trial.
Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia.
Carella AM, Frassoni F, Podestá M, Pungolino E, Pollicardo N, Ferrero R, Soracco M. Carella AM, et al. Among authors: ferrero r. J Hematother. 1994 Fall;3(3):199-202. doi: 10.1089/scd.1.1994.3.199. J Hematother. 1994. PMID: 7530135 Clinical Trial.
Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea.
Carella AM, Frassoni F, Pollicardo N, Pungolino E, Podestà M, Giordano D, Ferrero R, Soracco M, Benvenuto F, Figari O. Carella AM, et al. Among authors: ferrero r. Bone Marrow Transplant. 1994;14 Suppl 3:S34-7. Bone Marrow Transplant. 1994. PMID: 7535152 No abstract available.
GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model.
Ortiz DA, Peregrín N, Valencia M, Vinueza-Gavilanes R, Marín-Ordovas E, Ferrero R, Nicolás MJ, González-Aseguinolaza G, Arrasate M, Aragón T. Ortiz DA, et al. Among authors: ferrero r. Transl Neurodegener. 2024 Sep 20;13(1):49. doi: 10.1186/s40035-024-00441-w. Transl Neurodegener. 2024. PMID: 39304897 Free PMC article. No abstract available.
242 results